Nanobiotechnology: Market Research Report

Date: January 1, 2017
Pages: 267
Price:
US$ 4,950.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: N9ED653675FEN
Leaflet:

Download PDF Leaflet

Nanobiotechnology: Market Research Report
This report analyzes the worldwide markets for Nanobiotechnology in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as -
    Ablynx NVArrowhead Pharmaceuticals, Inc.Avadel Pharmaceuticals plcCaPtivate Pharmaceuticals LLCCelgene Corporation
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

A Curtain Raiser
Nanobiotechnology – The Next Big Thing
An Insight into the Global Nanobiotechnology Market
Major Market Drivers
Where Conventional Molecular Science Falls Short…Nanobio Steps In
Nanotechnology Revolutionizes Pharmaceuticals & Healthcare Sector
Nanomedicine Market to Achieve Phenomenal Growth
Opportunities Galore for Nanomedicine
Drug Delivery – A Promising Application Area for Nanotechnology
Benefits Offered by Nanostructures in Drug Delivery
Select Key Requirements for Development of Advanced Drug Delivery Systems
Nanotechnology Offers Huge Potential in Brain Disorder Treatment
High Demand for Nanobots and Nano Healthcare Devices
Nanotechnology Gaining Prominence for Treatment of Cancer
Nanotechnology in Drug Delivery: A Specialized Market Opportunity
Commercialization of Nanotechnology-based Medical Products Gains Momentum
Nanodiagnostic Products to Witness Strong Demand Growth
Dendrimers Serve as a Base to Build Multifunctional Nanodevices
Nanotechnology Rescues Poor Water Soluble Drugs from Abandonment
Huge Opportunities for Nanomaterials in the Medical Field
Commercial Opportunities in Healthcare Sector
Future Possibilities
Global Market for Fullerenes – An Insight
Dawn Breaks on Nanobiotechnology
Demystifying the Intriguing World of Nanobiotech
A Meeting Place of Medicine’s Best Solutions
Nanobiotechnology to Become Viable for All Drug Development Stages
Nanoparticles: The Foundation of Nanobiotechnology
Improved Optical Properties and Stability of Nanoparticles
Nanoemulsions
The Promise of Nanobiotechnology
Biological Weaponries against Diseases Come in Small Packages
Proffered Benefits of Nanobiotechnology
Opportunity & Beyond
Nanobiotechnology – Will it Live Up to the Expectations?
The Future of Nanobiotechnology: Shape of Things to Come
Nanobiotechnology: The Outer Limits
Futuristics: A Rumination
Conclusions

2. COMPETITIVE SCENARIO

Competition in Select Segments
Nanoparticles
Nanotubes and Fullerenes
Dendrimers
Small and Medium-Sized Enterprises Spearheading Product Development
List of Select Approved Nanotechnology-based Drug Delivery Devices
Status of Select Nanoscale Drug Delivery Devices
Collaborations Activity Picking Up Pace in Nanomedicine Domain

3. MARKET DYNAMICS

Present Status and Future Opportunities
Outlook
Developing Countries to Rise over the Horizon
Nanomaterials & Nanoparticles Witness Robust Activity
Focus on Improved Performance to Bring New Manufacturing Methods for Nanomaterials
Why Invest in Nanobiotechnology?
Private and Public Companies to Step Up Funding on Nanotechnology
United States Lead the Way in Government Funding
Increasing Awareness on Technology to Drive Growth
Demand for Novel Products to Push Up Growth
Nano-Enabled Drug Discovery Holds Tremendous Potential
Consolidation Sharpens the Industry’s Edge
The Regulatory Framework Evolves with the Technology
Nanobiotechnology Gathers a Miniscule Share in Biotechnology Patents

Table 1. Percentage Breakdown of Number of Nanotechnology Publications in USPTO & EPO by Region/Country (2016) (includes corresponding Graph/Chart)

Quantum Dot Patents Pose Legal Tangles
Miniaturized Liquid Handling Becomes Progressive
Trends in Nanotechnology Enabled Drug Delivery Systems
Robust Growth on the Cards

Table 2. Global Nanomedicine Market by Application (2015): Percentage Breakdown of the Market for Drug Delivery, Implants, In vivo Diagnostics and In vitro Diagnostics (includes corresponding Graph/Chart)

Patent Expiries: A Key Driver
Nanotechnology Enabled Drug Delivery to Exhume Unused Drugs

4. INDUSTRY CHALLENGES & ISSUES

Challenges
Commercial Exploration: A Treacherous Voyage
Conventional Medicine to Contest Nanomedicine Adoption
Complexity of Nanotechnology Based Diagnostics and Treatment Methods Pose Challenges
Nanomaterials Use: Weighed Down with Toxicity Concerns
Production Issues Continue to Plague Nanobiotech Industry
Lack of De Facto Standards: A Challenge to Reckon With
Embroilment over Ethical Issues
Social Relevance
Economic Relevance

5. INDUSTRY STRUCTURE

Industry Structure: A Quick Primer
A Peek into the Regulatory Framework
United States
Europe
A Closer Look at Regional Nano Efforts
United States: Unraveling the Country’s Edge

Table 3. Nanotechnology Patents in United States Patent and Trademark Office by Leading Countries: 2014-2016 (Sep) (includes corresponding Graph/Chart)
Table 4. Nanotechnology Patents In European Patent Office by Leading Countries: 2014-2016 (Sep) (includes corresponding Graph/Chart)
Table 5. Leading Countries in Terms of Number of Research Publications for Nanopolymeric Cardiac Scaffolds: 2005-2015 (June) (includes corresponding Graph/Chart)

Europe: Hot on the Heels of the US
Germany
France
United Kingdom
Scandinavia
Japan: A Noteworthy Region

6. NANOBIO’S EPOCHAL STRIDES IN MODERN MEDICINE

A Primer
Impact on Drug Delivery Systems
Benefits Offered
Drug Encapsulation
High Level of Specificity
Increase in Drug Solubility and Uptake
Greater Usage Flexibility
Impact on Molecular Diagnostic Imaging
Seeing the Unseen
Impact on Therapeutics
Silver Nanoparticles as Effective Antimicrobial Agents
Modern Day Nanomedicine: A Current Scenario
Nanomedicine: The Cynosure of All Eyes
Applications of Nanomedicine
Drug Delivery
Drugs/ Therapy
In Vivo Imaging
In Vitro Diagnostics
Biomaterials
Active Implants
Drug Delivery Systems Epitomized by Nanomedicine
Targeted NanoDrug Delivery & Release
Active and Passive Targeting Mechanisms in Drug Delivery
Sustained and Pulsatile Release Mechanisms in Drug Delivery
A Peek into Potential Nanobio Enabled Drug Carriers
Micelles
Liposomes
Dendrimers & Liquid Crystals
Nanoparticles
Polymeric Nanoparticles
Hydrogels
Molecularly Imprinted Polymers
Microelectromechanical Systems (MEMS)
Nanosuspensions
Fullerenes: A Platform for GenX Drug Delivery
Types of Nano-Based Drug Delivery Systems, Related Materials, and Structures
Dynamics of Regenerative Medicine
Tissue Engineering and Restorations
Nanotechnology Enabled Diagnostics
Promised Path Breaking Applications in Molecular Diagnostics & Imaging
In-Vitro Diagnostics
Nanoprobes & Implantable Devices in In-vivo Imaging
Nanocomposites in Molecular Labeling & Diagnostics
Laboratory-on-a-Chip – A Revolutionary Technology in Biomolecular Detection
Biosensors – Heralding New Opportunities in Molecular Diagnostics
Nanobiosensors – A New Approach to Diagnostics Testing
Despite Huge Potential … Key Hurdles Remain in Commercialization
Magnetic Nanoparticles for Imaging Applications in MRI
Dendrimers Promise Milestone Applications in MRI
Conclusions
Gauging the Real World Impact of Nanobiotech on Cancer: A Case Study
Quantum Dots Cock a Snook at Traditional Anti-Body Labeling Agents
Chemotherapeutic Reengineering & Gene Therapy: New Treatment Regimes
Futuristic Applications
Bio-molecular Motors
Genetic and Tissue Engineering
External Tissue Products
Internal Tissue Implants
Dental and Bone Replacement
Protein and Gene Analysis
Nanorobot Therapeutics
Laboratory-on-chip (LOC): A Portable Diagnostic Laboratory
Organs-On-A-Chip: Mimics Physiological Activities of Human Organs
Medical Diagnostic Sensors
Nano Medical Devices – From Surgical Tools to Contact Lenses
Nanoengineered Prosthetics
Nanotubes – Potential Drug Delivery Vehicles

7. INNOVATIONS & ADVANCEMENTS

ASTAR Researchers Develop Nano-Sized Drug Molecules for Cancer Treatment
MIT Researchers Develop Nanodevice for Fighting Against Cancer Drug Resistance
Gold Nanotubes for Several Applications in the Fight Against Cancer
IBM Research Working on NanoDLD Technology for Early Diagnosis of Cancer and other Diseases
Antifungal Bionanocomposites for Medical Devices
DNA Nanostructures for Smart Diagnosis and Drug Delivery
Japanese Scientists Develop CNTs with Polymeric Coatings for Enhanced Drug Delivery
Other Noteworthy Nanotechnology Related Technology Innovations

8. CONCEPTUAL OVERVIEW

Nanotechnology: An Introduction
A Revolution in the Making
Nanobiotechnology: An Exposition
Nanobiotechnology & Medicine
Nanobiotechnology & Biofuels
Analysis of Major Technology Segments
Nanomaterials
Nanoparticles
Nanoparticles in Labeling or Bio Tagging
Nanoparticles as Biomarkers
Classification of Nanoparticles
Solid Nanoparticles
Solid Lipid Nanoparticles
Calcium Phosphate Nanoparticles
Dendrimers
Cubosomes
Nanocomposites
Lamellar Nanocomposites
Nanostructured Materials and Membranes
Quantum Dots
Nanotubes and Fullerenes
Fullerenes
Nanotubes
Carbon Nanotubes (CNTs)
Other Nanomaterials
Nanoshells
Nanohorns
Nanocapsules
Nanodevices
Nanotools
Select Nanotools
Atomic Force Microscopes
Hot Embossing Lithography
Dip-Pen Nanolithography
Nanotechnology for Diseases Treatment
Cancer
Parkinson’s Disease
Alzheimer’s Disease
Tuberculosis
Dentistry
Ophthalmology
Surgery

9. GLOBAL RESEARCH CENTERS AND INSTITUTIONS

Cornell's Nanobiotechnology Center (USA)
Institute of Bioengineering and Nanotechnology (Singapore)
Michigan Nanotechnology Institute for Medicine and Biological Sciences (MNIMBS) (USA)
The Tyndall National Institute (Ireland)

10. RECENT INDUSTRY ACTIVITY

Vectura Group Inks Merger Agreement with Skyepharma
Flamel Technologies to Merge with Avadel Pharmaceuticals
Pfizer to Acquire BIND Therapeutics Assets
Janssen Sciences Ireland Enters into Collaboration with ViiV Healthcare
Tekna Holdings Canada Inks Agreement with National Research Council of Canada
Roche and BioMed X Sign a Collaboration Agreement
Ablynx Enters into Exclusive Research Collaboration with Genzyme
Pfizer Exercises Option to Develop and Commercialize Accurin
BIND Therapeutics Inks Joint Research and Development Agreement with Merck

11. FOCUS ON SELECT GLOBAL PLAYERS

Ablynx NV (Belgium)
Arrowhead Pharmaceuticals, Inc. (USA)
Avadel Pharmaceuticals plc (Ireland)
CaPtivate Pharmaceuticals LLC (USA)
Celgene Corporation (USA)
ELITechGroup (France)
GlaxoSmithKline Plc. (UK)
Johnson & Johnson (USA)
Merck & Co., Inc. (USA)
NanoBio Corporation (USA)
Nanophase Technologies Corporation (USA)
pSivida Corp. (USA)
Sigma-Aldrich Corp. (USA)
Starpharma Holdings Ltd. (Australia)
Vectura Group plc (UK)

12. GLOBAL MARKET PERSPECTIVE

Table 6. World Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 7. World Historic Review for Nanobiotechnology by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 8. World 14-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Revenues for US, Japan, Europe, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
Industry Overview
Academic Research Lending Strength to Creation of Novel Nanobiotech Products

Table 9. Number of Drugs Approved by FDA: 2001-2016 (includes corresponding Graph/Chart)

Public Sector Funding

Table 10. National Nanotechnology Initiative Budget in US$ Million by Agency (2015-2017) (includes corresponding Graph/Chart)

Connecticut – A Key Region with Focus on Nanomedicine
Patent Activity in Nanomedicine Domain
Major Nanobiotechnology Institutions and Centers
The Nanobiotechnology Center (NBTC)
Key Technological Advances Achieved by NBTC
Principal NBTC Partners
Michigan Nanotechnology Institute for Medicine and Biological Sciences (MNIMBS)
Centers of Cancer Nanotechnology Excellence (CCNEs)
Regulatory Environment
FDA’s Regulatory Approach to Nanotechnology Products
The Perils of Current Regulatory Status on Nanostructures
Few Challenges Faced by FDA
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 11. US Recent Past, Current & Future Analysis for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 12. US Historic Review for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. JAPAN

A. Market Analysis
Outlook

Table 13. R&D Expenditure in Japan (2015): Percentage Breakdown of Expenditure by Industrial Sector for Energy, Environmental S&T, ICTs, Life sciences, Materials, Nanotechnology, and Others (includes corresponding Graph/Chart)

Nanomedicines in Japan – An Overview
List of Select Nanomedicines Approved in Japan
Regulations on Nanomedicine in Japan
B. Market Analytics

Table 14. Japanese Recent Past, Current & Future Analysis for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 15. Japanese Historic Review for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. EUROPE

A. Market Analysis
The Rise of Nanobiotechnology in Europe
EU Gears Up for Clarity on Nanomedicine Regulations
Market Overview
Nano2Life Network
Public Sector Funding
Regulatory Environment
Registration for Novel Nanobiotech Drugs Pose Major Bottlenecks
A Snapshot of Nanotherapeutic Products in the EU
List of Select Oral Nanotherapeutic Products
List of Select Nanotherapeutic Products for Parenteral Administration
List of Select Nanotherapeutic Products for Parenteral Administration in the EU
Focus on Select Markets
Germany
A Regional Hub for Nanomedicine Research
France
Nanotechnology and Nanomedicine – An Overview
Regulations on Nanomaterials
United Kingdom
UK Bets on Advancing Nanotechnology
Russia
Russian Biotech Players Eye Partnerships with Indian Counterparts
Rest of Europe
Ireland
Market Overview
Key Research Institutions/Centers in Nanobiotechnology
The Tyndall National Institute
The Centre for Research on Adaptive Nanostructures and NanoDevices
The National Centre for Sensor Research
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 16. European Recent Past, Current & Future Analysis for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 17. European Historic Review for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. REST OF WORLD

A. Market Analysis
Public Sector Funding
Focus on Select Markets
Australia
Market Overview
Major Institutions
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
China
New Findings Reinforce Role of Silica Nanoparticles in Drug Delivery and Diagnostics
Nanotechnology Patent Profile in China
India
Market Overview
Nanotechnology to Spur Indian Pharmaceutical Industry
Government Takes Big Initiatives to Promote Nanobiotechnology
Agriculture, Livestock Sectors to Warm Up to Nanobiotechnology Benefits
South Korea
Taiwan
Nanotechnology in Medicine – Small Yet Growing Segment in Taiwan
Iran
Strategic Corporate Development
Starpharma Holdings Ltd. – A Major Australian Player
B. Market Analytics

Table 18. Rest of World Recent Past, Current & Future Analysis for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 19. Rest of World Historic Review for Nanobiotechnology Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled:
The United States (49)
Canada (2)
Japan (1)
Europe (19)
  France (2)
  Germany (6)
  The United Kingdom (4)
  Rest of Europe (7)
Asia-Pacific (Excluding Japan) (5)
Middle East (3)
Skip to top


Nanobiotechnology: Market Research Report US$ 4,450.00 Feb, 2010 · 827 pages
Video Encoders: Market Research Report US$ 4,950.00 Jan, 2015 · 328 pages
Biogas Plants: Market Research Report US$ 4,500.00 Jan, 2016 · 296 pages
Blinds and Shades: Market Research Report US$ 4,500.00 Jan, 2016 · 277 pages
Software-As-A-Service (SaaS): Market Research Report US$ 4,950.00 Feb, 2010 · 891 pages

Ask Your Question

Nanobiotechnology: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: